chartexchange

IMUX
Immunic, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:57 PM EST
7.50USD+2.319%(+0.17)175,591
Pre-marketNov 18, 2026 8:48:30 AM EST
7.55USD+3.001%(+0.22)
After-hoursNov 18, 2026 4:00:30 PM EST
7.52USD+0.267%(+0.02)
Loading…
Loading…
119.42M
Healthcare
Biotechnology
HQ
New York, NY, USA
Previous Close
$7.33
Beta
1.51
52-Week High
$17.43 2026-08-19
52-Week Low
$5.06 2025-12-30
SMA 50
$8.38
SMA 200
$11.57
Avg. Vol 10D
187,155
Avg. Vol 30D
294,115
Avg. Vol 90D
287,880
Relative Vol
0.60
12.01M
0.7200%
3,875
Apr 27, 2026 · 1-for-10 (reverse)
IMUX Profile

immunic, inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases, including relapsing-remitting multiple sclerosis, ulcerative colitis, crohn's disease, and psoriasis. its lead development program is imu-838, a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme dihydroorotate dehydrogenase, which is in phase 2 clinical development for treatment of ulcerative colitis and relapsing-remitting multiple sclerosis, as well as in phase 2 trial to treat crohn's disease. the company is also developing imu-935, an inverse agonist of rorgt; and imu-856 for the restoration of the intestinal barrier function in patients suffering from diseases, such as inflammatory bowel disease, irritable bowel syndrome with diarrhea, immune checkpoint inhibitor induced colitis, and other intestinal barrier function diseases. immu

IMUX Performance
PeriodPriceDateChangeBeta
1W7.792026-11-12-3.47%2.042
1M6.992026-10-19+7.58%1.943
3M16.452026-08-19-54.29%1.662
6M11.602026-05-19-35.17%1.755
1Y7.132025-11-19+5.42%1.514
2Y10.502024-11-19-28.38%—
5Y93.702021-11-19-91.97%1.184
IMUX Stock Summary

Immunic, Inc. Common Stock (NASDAQ:IMUX) stock price today is $7.52, and today's volume is 175,591. IMUX is up 2.592% today. The 30 day average volume is 294,115. IMUX market cap is $119.42M with 15.88M shares outstanding.